AVEO - AVEO PHARMACEUTICALS INC
Form DEF 14A Period: MAY.30.12 Date Filed: APR.27.12
Transcript Split
  
  
     
Move to First Section Move to Last Section
INDEX
ItemizedPage-by-Page
  Form DEF 14A (Entire Filing)

Filing Body

Page 1: UNITED STATES

Page 2: 75 SIDNEY STREET

Page 3: TABLE OF CONTENTS

Page 4: AVEO PHARMACEUTICALS, INC.

Page 5: IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING

Page 6: If your shares are held in street name,

Page 7: your broker may not vote with respect to these proposal and those votes will be counted as broker no

Page 8: Proposal 3 Ratification of Appointment of Independent Registered Public Accounting Firm

Page 9: HOUSEHOLDING OF ANNUAL MEETING MATERIALS

Page 10: N/A

Page 11: N/A

Page 12: SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Page 13: Kenneth M. Bate

Page 14: Tuan Ha-Ngoc

Page 15: Kenneth E. Weg

Page 16: CORPORATE GOVERNANCE

Page 17: Role of the Board

Page 18: Board of Directors Meetings and Attendance

Page 19: Compensation Committee

Page 20: Director Nomination Process

Page 21: Communicating with the Independent Directors

Page 22: Report of the Audit Committee

Page 23: Audit Committee Pre-Approval Policies and Procedures

Page 24: CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS

Page 25: Related Person Transactions

Page 26: EXECUTIVE AND DIRECTOR COMPENSATION

Page 27: Overview of our Executive Compensation

Page 28: Objectives of our Executive Compensation Program

Page 29: N/A

Page 30: The Chief Executive Officer s Role in the Compensation Process

Page 31: N/A

Page 32: Annual Cash Incentive Program

Page 33: N/A

Page 34: N/A

Page 35: Equity Compensation

Page 36: N/A

Page 37: Other Benefits

Page 38: Summary Compensation Table for the Years Ended December 31, 2009, 2010 and 2011

Page 39: N/A

Page 40: Grants of Plan-Based Awards for the Year Ended December 31, 2011

Page 41: N/A

Page 42: Outstanding Equity Awards at December 31, 2011

Page 43: Option Exercises

Page 44: Severance and Change in Control Agreements with Named Executive Officers

Page 45: Key Employee Change in Control Severance Benefits Plan

Page 46: N/A

Page 47: Equity Compensation Plan Information

Page 48: Compensation Committee Report

Page 49: N/A

Page 50: N/A

Page 51: Consulting Agreement with Dr. Ronald DePinho

Page 52: Consulting Agreement with Dr. Raju Kucherlapati

Page 53: Our board of directors recommends that stockholders vote to approve

Page 54: OTHER MATTERS

Page 55: THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

Page 56: Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:

   CURRENT PAGE
    Download Current Page as a Word Document  Download Current Page as a PDF Document    Download Excel File of Financials